Takeda In Talks to Buy PE-Backed Nycomed

Japanese drugmaker Takeda Pharmaceutical Co. is in talks to buy buy Swiss rival Nycomed in a deal that could reach about $14.2 billion, Reuters reported, citing a story by Bloomberg. Nycomed is owned by Nordic Capital and Credit Suisse Group AG's private-equity unit. A deal for the company could be announced as early as next week, Reuters said.

North AmericaUSBriefs